October 08, 2020 Mapping the transatlantic divide for biotech flotations A look at how drug developers fare after floating in Europe suggests why many tread a path to the US and a Nasdaq listing.
October 12, 2017 Another huge quarter in 2017 for biotech flotations Another billion dollar quarter for biotech IPOs signals that investor appetite for high-risk offerings is strong.
